Methyl 2-(2-hydroxy-4-methylphenyl)-2-oxoacetate

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: Methyl 2-(2-hydroxy-4-methylphenyl)-2-oxoacetate
• 英文别名: methyl 2-(2-hydroxy-4-methylphenyl)-2-oxoacetate
• 化学式: C₁₀H₁₀O₄
• 分子量: 194.18
• InChiKey: JLHBQAVRUJTZIY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• TAK1 KINASE INHIBITORS, COMPOSITIONS, AND USED RELATED THERETO
  申请人：Davies Huw M. L.

  公开号：US20140249199A1

  公开（公告）日：2014-09-04

  The disclosure relates to TAK1 inhibitors, compositions, and uses related thereto. In certain embodiments, the disclosure relates to compounds of formula (I), pharmaceutical compositions having a compound of formula (I), and methods of treating or preventing cancer by administering an effective amount of a pharmaceutical composition having a compound of formula (I) to a subject in need thereof.

  该披露涉及TAK1抑制剂，相关的组合物和用途。在某些实施例中，该披露涉及公式(I)化合物，具有公式(I)化合物的制药组合物，以及通过向需要的受体施用具有公式(I)化合物的制药组合物的有效量来治疗或预防癌症的方法。
• TAK1 Kinase Inhibitors, Compositions, and Uses Related Thereto
  申请人：Emory University

  公开号：US20170369417A1

  公开（公告）日：2017-12-28

  The disclosure relates to TAK1 inhibitors, compositions, and uses related thereto. In certain embodiments, the disclosure relates to compounds of formula I, pharmaceutical compositions having a compound of formula I, and methods of treating or preventing cancer by administering an effective amount of a pharmaceutical composition having a compound of formula I to a subject in need thereof.
• US9751825B2
  申请人：——

  公开号：US9751825B2

  公开（公告）日：2017-09-05